Articles tagged "Liver cirrhosis"

2020 American Transplant Congress
Acute on Chronic Liver Failure (ACLF) Patients Have a Dynamic and Progressive Clinical Course Until Receiving a Liver Transplant: A 5-Year Study at the National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico
E. Cervantes-Alvarez¹, M. J. Lizardo-Thiebaud¹, E. Alatorre-Arenas¹, O. Mendez-Guerrero¹, S. Yarza-Regalado¹, A. Torre¹, M. Vilatobá², D. Kershenobich¹, C. A. Huang³, N. Navarro-Alvarez¹
¹Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ²Surgery, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ³Surgery, University of Colorado Anschutz Medical Campus, DENVER, CO
*Purpose: To characterize the clinical course of patients diagnosed with acute on chronic liver failure (ACLF) before undergoing liver transplantation. ACLF is characterized by an…
2020 American Transplant Congress
Black Patients with Cirrhosis Have Worse Liver-Related Outcomes: A Large Multicenter Study
N. R. Mazumder¹, K. Atiemo², K. Jackson³, A. Daud⁴, A. Kho³, L. G. Gabra⁵, J. Levitsky¹, D. P. Ladner⁴
¹Gastroenterology and Hepatology, Northwestern University, Chicago, IL, ²Department of Surgery, Tulane Abdominal Transplant Institute, New Orleans, LA, ³Center for Health Information Partnerships, Northwestern University, Chicago, IL, ⁴Transplant Surgery, Northwestern University, Chicago, IL, ⁵Feinberg School of Medicine, Northwestern University, Chicago, IL
*Purpose: Racial disparity is influential in liver cirrhosis. Estimates of its magnitude have been limited by lack of large, longitudinal data that track patients from…
2020 American Transplant Congress
Galectin-3 as a Biomarker of Disease Severity in Acute-on-Chronic Liver Failure
E. Cervantes-Alvarez¹, F. Tejeda-Dominguez², M. Lizardo-Thiebaud², E. Alatorre-Arenas³, O. Méndez-Guerrero¹, S. Yarza-Regalado¹, D. Kershenobich¹, A. Torre¹, M. Vilatobá⁴, C. A. Huang⁵, N. Navarro-Alvarez¹
¹Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ²Molecular Biology, Panamerican University, School of Medicine, Mexico City, Mexico, ³University of the Americas Puebla, School of Medicine, Puebla, Mexico, ⁴Surgery, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ⁵Surgery, University of Colorado Anschutz Medical Campus, Denver, CO
*Purpose: A matter of great importance is the discovery of alternative diagnostic measures that can detect liver disease at an early stage, especially when at…
2020 American Transplant Congress
Safety and Efficacy of Endoscopic Transpapillary Gallbladder Stenting for Symptomatic Gallbladder Disease in Cirrhosis: A Systematic Review and Meta-Analysis
K. F. Haq¹, U. Iqbal², M. Khan³, F. Kamal⁴, S. Solanki⁵, R. Chakinala⁵, M. Siddiqui¹, M. Abu Ghanimeh¹, O. Sadiq¹, A. Watson¹, T. Zuchelli¹, R. Salgia¹
¹Gastroenterology & Hepatology, Henry Ford Hospital, Detroit, MI, ²Medicine, Geisinger Medical Center, Danville, PA, ³Gastroenterology & Hepatology, University of Alabama, Birmingham, AL, ⁴Gastroenterology & Hepatology, University of Tennessee, Knoxville, TN, ⁵Medicine, Guthrie Hospital, Sayre, PA
*Purpose: Endoscopic transpapillary gallbladder (cystic duct) stenting has been shown to be an effective treatment option for symptomatic gallbladder disease in patients with cirrhosis. However,…
2020 American Transplant Congress
Impact of Donor Noninvasive Liver Fibrotic Score on Graft Injury in Liver Transplantation
S. M. Younan, T. Ito, H. Hirao, A. Aziz, A. E. Murray, J. DiNorcia III, V. G. Agopian, D. G. Farmer, R. W. Busuttil, F. M. Kaldas
The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA
*Purpose: The increasing prevalence of obesity and metabolic syndrome, has led to a corresponding increase in steatotic livers being utilized in liver transplantation (LT). These…
2020 American Transplant Congress
Frailty Prior to Hospital Discharge Predicts Mortality after Cirrhosis-Related Admissions
M. Serper¹, S. Tao², P. Garren¹, D. Peyton¹, M. A. Dunn², K. Reddy¹, A. Gougol², A. Duarte-Rojo²
¹University of Pennsylvania, Philadelphia, PA, ²University of Pittsburgh, Pittsburgh, PA
*Purpose: Inpatient frailty assessment and its utility in clinical care is understudied in liver transplant (LT) candidates. Study objectives were to quantify physical frailty among…
2020 American Transplant Congress
Left Lobe Living Donor Liver Transplantation Using Rapid Procedure in a Cirrhotic Patient with Hepatocellular Carcinoma with a GRWR of 0.35
D. Balci¹, O. Kirimker¹, M. Kologlu², U. Goktug¹, E. Ustuner³, S. Karadag⁴, E. Er⁵, G. Cinar⁶, M. Bayar⁴, A. Yilmaz⁴, A. Azap⁶, K. Karayalcin¹
¹General Surgery and Transplantation, Ankara University, Ankara, Turkey, ²Pediatric Surgery and Transplantation, Ankara University, Ankara, Turkey, ³Radiology, Ankara University, Ankara, Turkey, ⁴Anesthesiology, Ankara University, Ankara, Turkey, ⁵Gastroenterology, Ankara University, Ankara, Turkey, ⁶Infectious Disease, Ankara University, Ankara, Turkey
*Purpose: Here, we describe a new approach using Rapid Procedure, a 2 stage hepatectomy technique, with living donor liver transplantation (LDLT) in the cirrhotic setting…
2020 American Transplant Congress
Characterization of Gut Microbiome in Liver Transplant Recipients with Non-Alcoholic Steatohepatitis
S. Sataphaty¹, P. Banerjee², J. Pierre³, R. Heda³, S. Dutta³, D. D. Higgins⁴, V. Mas⁵, S. Khan⁶, V. Mupparaju³, S. R. Nair⁷, J. D. Eason⁸, D. Kleiner⁹, D. Maluf¹⁰
¹Department of Surgery, Division of Hepatology and Sandra Atlas Bass Center for Liver Diseases, Northwell Health, NYC, NY, ²School of Public Health, University of Memphis, Memphis, TN, ³University of Tennessee Health Science Center, Memphis, TN, ⁴University of Memphis, Memphis, TN, ⁵James D Eason Transplant Institute, Memphis, TN, ⁶Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NYC, NY, ⁷Department of Surgery, James D Eason Transplant Institute, Memphis, TN, ⁸Department of Surgery, James D Eason Transplant Institute, NYC, TN, ⁹Laboratory of Pathology/National Cancer Institute, Bethesda, WA, ¹⁰Department of Surgery_ University of Tennessee, James D Eason Transplant Institute, NYC, TN
*Purpose: Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) is a growing problem globally and recurs even after liver transplant (LT).…
2020 American Transplant Congress
Bedside Ultrasound to Assess for Sarcopenia in Cirrhotic Patients Undergoing Inpatient Liver Transplant Evaluation
M. Aguilar¹, E. A. Rodriguez¹, A. Andrekus², S. Buckner-Petty², N. Dahiya², E. J. Carey²
¹GI/Hepatology, Mayo-Arizona, Scottsdale, AZ, ²Mayo-Arizona, Scottsdale, AZ
*Purpose: Sarcopenia is routinely assessed during outpatient evaluation for liver transplant (LT) candidacy in cirrhotic patients as it is associated with poor clinical outcomes. Skeletal…
2020 American Transplant Congress
Using Nudges for Liver Transplantation Prehabilitation: Results from PRIMER (Prehabilitation Intervention to Maximize Early Recovery), a Home-Based Behavioral Pilot and Feasibility Trial
M. Serper, L. S. Jones, T. Clement, K. Reddy, A. Duarte-Rojo, P. P. Reese
University of Pennsylvania, Philadelphia, PA
*Purpose: Data on effective prerehabilitation in liver transplant (LT) is limited. We studied the feasibility and acceptability of a pilot randomized controlled trial of a…

« Previous Page
1
…
4
5
6
7
8
…
14
Next Page »